Suppr超能文献

相似文献

1
Effect of Cystone® on urinary composition and stone formation over a one year period.
Phytomedicine. 2011 Jul 15;18(10):863-7. doi: 10.1016/j.phymed.2011.01.018. Epub 2011 Mar 17.
2
Cystone® for 1 year did not change urine chemistry or decrease stone burden in cystine stone formers.
Urol Res. 2011 Jun;39(3):197-203. doi: 10.1007/s00240-010-0334-x. Epub 2010 Dec 16.
3
Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
Arch Ital Urol Androl. 2015 Jul 7;87(2):105-20. doi: 10.4081/aiua.2015.2.105.
5
The urinary microbiota composition and functionality of calcium oxalate stone formers.
Front Cell Infect Microbiol. 2024 Jun 7;14:1394955. doi: 10.3389/fcimb.2024.1394955. eCollection 2024.
6
Calcium oxalate stone formation in genetic hypercalciuric stone-forming rats.
Kidney Int. 2002 Mar;61(3):975-87. doi: 10.1046/j.1523-1755.2002.00190.x.
7
[Pathophysiology, diagnosis and conservative therapy in calcium kidney calculi].
Ther Umsch. 2003 Feb;60(2):79-87. doi: 10.1024/0040-5930.60.2.79.
9
Comparison of patients with idiopathic calcium phosphate and calcium oxalate stones.
Medicine (Baltimore). 1991 Nov;70(6):345-59. doi: 10.1097/00005792-199111000-00001.
10
Influence of cranberry juice on the urinary risk factors for calcium oxalate kidney stone formation.
BJU Int. 2003 Nov;92(7):765-8. doi: 10.1046/j.1464-410x.2003.04472.x.

引用本文的文献

2
Systematic review of pharmacological, complementary, and alternative therapies for the prevention of calcium oxalate stones.
Asian J Urol. 2025 Apr;12(2):169-188. doi: 10.1016/j.ajur.2024.04.006. Epub 2024 Jul 4.
3
Phytotherapy in Urolithiasis: An Updated Overview of Current Knowledge.
J Clin Med. 2025 Apr 22;14(9):2885. doi: 10.3390/jcm14092885.
4
Efficacy of Bur. extract in ethylene glycol-induced urolithiasis model in SD rats.
Front Pharmacol. 2022 Aug 29;13:974947. doi: 10.3389/fphar.2022.974947. eCollection 2022.
7
The protective effects of an herbal agent tutukon on ethylene glycol and zinc disk induced urolithiasis model in a rat model.
Urolithiasis. 2016 Nov;44(6):501-507. doi: 10.1007/s00240-016-0889-2. Epub 2016 May 9.
8
Cystone® for 1 year did not change urine chemistry or decrease stone burden in cystine stone formers.
Urol Res. 2011 Jun;39(3):197-203. doi: 10.1007/s00240-010-0334-x. Epub 2010 Dec 16.

本文引用的文献

1
Medical therapy to facilitate urinary stone passage: a meta-analysis.
Lancet. 2006 Sep 30;368(9542):1171-9. doi: 10.1016/S0140-6736(06)69474-9.
2
Therapeutic action of citrate in urolithiasis explained by chemical speciation: increase in pH is the determinant factor.
Nephrol Dial Transplant. 2006 Feb;21(2):361-9. doi: 10.1093/ndt/gfi211. Epub 2005 Oct 25.
3
Direct and indirect costs of nephrolithiasis in an employed population: opportunity for disease management?
Kidney Int. 2005 Oct;68(4):1808-14. doi: 10.1111/j.1523-1755.2005.00599.x.
5
Effect of aqueous extract from Herniaria hirsuta L. on experimentally nephrolithiasic rats.
J Ethnopharmacol. 2004 Nov;95(1):87-93. doi: 10.1016/j.jep.2004.06.028.
6
Phyllanthus niruri normalizes elevated urinary calcium levels in calcium stone forming (CSF) patients.
Urol Res. 2004 Oct;32(5):362-6. doi: 10.1007/s00240-004-0432-8. Epub 2004 Jun 19.
7
Increasing prevalence of kidney stones in the United States.
Kidney Int. 2003 May;63(5):1951-2. doi: 10.1046/j.1523-1755.2003.00942.x.
8
Time trends in reported prevalence of kidney stones in the United States: 1976-1994.
Kidney Int. 2003 May;63(5):1817-23. doi: 10.1046/j.1523-1755.2003.00917.x.
9
Urinary phytate in calcium oxalate stone formers and healthy people--dietary effects on phytate excretion.
Scand J Urol Nephrol. 2000 Jun;34(3):162-4. doi: 10.1080/003655900750016526.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验